LFMD LIFEMD INC

LifeMD to Participate in Two Investor Conferences in September

LifeMD to Participate in Two Investor Conferences in September

NEW YORK, Aug. 30, 2023 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD) today announced that management will be participating in two upcoming investor conferences in September.

  • H.C. Wainwright 25th Annual Global Investment Conference, September 11-13, 2023 at the Lotte New York Palace Hotel in New York City. Management will deliver a company presentation on Wednesday, September 13th at 3:30 p.m. Eastern Time and will be available for one-on-one meetings with investors. A live and archived webcast of the presentation will be available in the section of LifeMD’s website.

  • Cantor Fitzgerald Global Healthcare Conference, September 26-28, 2023 at the InterContinental New York Barclay in New York City. Management will participate in a fireside chat on Thursday, September 28th at 9:45 a.m. Eastern Time and will be available for one-on-one meetings during the event.

About LifeMD

LifeMD is a direct-to-patient telehealth company with a portfolio of brands that offer virtual primary care, diagnostics and specialized treatment for men’s and women’s health, allergy & asthma and dermatologic conditions. By leveraging its proprietary technology platform, 50-state affiliated medical group and nationwide mail-order pharmacy network, LifeMD is making top-notch healthcare available and affordable to anyone. To learn more, go to .

Company Contact:

LifeMD, Inc.

Marc Benathen, CFO



EN
30/08/2023

Underlying

LFMDLIFEMD INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on LIFEMD INC

 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with No...

LifeMD Offers Ozempic® at $499 Per Month through Collaboration with Novo Nordisk Ozempic® is now available at this reduced price to eligible self-pay LifeMD patients NEW YORK, Sept. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care, today announced an additional offering through its collaboration with Novo Nordisk that provides access to Ozempic® (semaglutide), a GLP-1 RA for patients with type 2 diabetes, at $499 per month. Through LifeMD’s integration with NovoCare® Pharmacy, eligible self-pay and uninsured patients, as well as insured patients w...

September 30, 2025 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities ...

LifeMD to Participate in the ROTH 4th Annual Healthcare Opportunities Conference NEW YORK, Sept. 25, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the ROTH 4th Annual Healthcare Opportunities Conference, which will be held October 9, 2025 at the Metropolitan Club in New York City. Management will hold one-on-one meetings with investors throughout the day. Investors can register for the conference by contacting their ROTH Capital Partners representative. About LifeMD, Inc. LifeMD® is a leading provider...

September 25, 2025 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Pr...

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2025, to holders of record at the close of business on October 3, 2025. About LifeMD, Inc.LifeMD® is a leading provider of virtual primary c...

September 23, 2025 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliv...

LifeMD Expands Pharmacy Services with Non-Sterile Compounding to Deliver Personalized, Cost-Efficient Therapies at Scale Enhanced Affiliated Pharmacy Capabilities Support Specialized Therapies, Seamless Patient Experience, and Margin Expansion NEW YORK, Sept. 18, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced the expansion of its state-of-the-art affiliated pharmacy to include advanced non-sterile compounding capabilities for oral and topical medications. This milestone extends LifeMD’s pharmacy growth strategy by enabling ...

September 18, 2025 1 EN
 PRESS RELEASE
Free
LFMD LIFEMD INC

LifeMD to Participate in Three Investor Conferences During September

LifeMD to Participate in Three Investor Conferences During September NEW YORK, Aug. 28, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of September: Cantor Fitzgerald Global Healthcare Conference, September 3-5 at the New York Marriott Marquis. Management will participate in a fireside chat on Wednesday, September 3rd at 8:35 a.m. Eastern time and will be available for one-on-one meetings with investors.H.C. Wainwright 27th Annual Gl...

August 28, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch